Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 71.55B | 71.55B | 72.57B | 83.66B | 88.13B | 99.69B |
Gross Profit | 17.24B | 17.24B | 17.96B | 20.58B | 21.47B | 25.09B |
EBITDA | 3.77B | 2.97B | 2.39B | 858.00M | 3.51B | 7.14B |
Net Income | 405.00M | 405.00M | -1.60B | 78.00M | -826.00M | 2.86B |
Balance Sheet | ||||||
Total Assets | 55.97B | 55.97B | 60.72B | 64.12B | 65.75B | 69.23B |
Cash, Cash Equivalents and Short-Term Investments | 13.22B | 13.22B | 16.42B | 19.18B | 18.66B | 20.12B |
Total Debt | 7.32B | 7.32B | 8.38B | 7.71B | 7.38B | 8.05B |
Total Liabilities | 35.55B | 35.55B | 38.92B | 39.92B | 40.68B | 41.37B |
Stockholders Equity | 20.09B | 20.09B | 21.40B | 23.52B | 23.96B | 26.22B |
Cash Flow | ||||||
Free Cash Flow | -641.00M | 0.00 | 907.00M | 4.28B | 3.56B | 9.62B |
Operating Cash Flow | -641.00M | 0.00 | 926.00M | 4.30B | 3.58B | 9.62B |
Investing Cash Flow | -2.13B | 0.00 | -52.00M | -1.20B | 3.30B | -11.07B |
Financing Cash Flow | 360.00M | 0.00 | -1.36B | -1.99B | -3.68B | -2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $1.86B | 9.04 | 5.36% | 5.26% | -7.23% | -27.81% | |
77 Outperform | $9.01B | 15.91 | 29.76% | 4.58% | -2.44% | -10.74% | |
72 Outperform | $4.35B | 105.36 | 2.85% | 2.56% | -11.58% | -87.27% | |
62 Neutral | $4.64B | 9.74 | 11.31% | 4.14% | -3.43% | 169.28% | |
61 Neutral | $18.02B | 12.77 | -0.74% | 3.01% | 1.30% | -13.03% | |
60 Neutral | ― | ― | 2.20% | 120.00% | |||
56 Neutral | $2.51B | 44.74 | 1.96% | 13.40% | -2.04% | ― |